Table of Content

Table of Contents
Table of Contents
1 Industry Overview
1.1 Proliferative Vitreoretinopathy (PVR) Therapeutics Industry
Figure Proliferative Vitreoretinopathy (PVR) Therapeutics Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Proliferative Vitreoretinopathy (PVR) Therapeutics
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Proliferative Vitreoretinopathy (PVR) Therapeutics
1.2.2 Downstream
Table Application Segment of Proliferative Vitreoretinopathy (PVR) Therapeutics
Table Global Proliferative Vitreoretinopathy (PVR) Therapeutics Market 2016-2026, by Application, in USD Million
1.2.3 COVID-19 Impact
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Proliferative Vitreoretinopathy (PVR) Therapeutics Market by Type
3.1 By Type
3.1.1 PRM-167
Table Major Company List of PRM-167
3.1.2 XOMA-089
Table Major Company List of XOMA-089
3.1.3 Others
Table Major Company List of Others
3.2 Market Size
Table Global Proliferative Vitreoretinopathy (PVR) Therapeutics Market 2016-2020, by Type, in USD Million
Figure Global Proliferative Vitreoretinopathy (PVR) Therapeutics Market Growth 2016-2020, by Type, in USD Million
Table Global Proliferative Vitreoretinopathy (PVR) Therapeutics Market 2016-2020, by Type, in Volume
Figure Global Proliferative Vitreoretinopathy (PVR) Therapeutics Market Growth 2016-2020, by Type, in Volume
3.3 Market Forecast
Table Global Proliferative Vitreoretinopathy (PVR) Therapeutics Market Forecast 2021-2026, by Type, in USD Million
Table Global Proliferative Vitreoretinopathy (PVR) Therapeutics Market Forecast 2021-2026, by Type, in Volume
4 Major Companies List
4.1 Novartis AG (Company Profile, Sales Data etc.)
4.1.1 Novartis AG Profile
Table Novartis AG Overview List
4.1.2 Novartis AG Products & Services
4.1.3 Novartis AG Business Operation Conditions
Table Business Operation of Novartis AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Promedior Inc (Company Profile, Sales Data etc.)
4.2.1 Promedior Inc Profile
Table Promedior Inc Overview List
4.2.2 Promedior Inc Products & Services
4.2.3 Promedior Inc Business Operation Conditions
Table Business Operation of Promedior Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 RXi Pharmaceuticals Corp (Company Profile, Sales Data etc.)
4.3.1 RXi Pharmaceuticals Corp Profile
Table RXi Pharmaceuticals Corp Overview List
4.3.2 RXi Pharmaceuticals Corp Products & Services
4.3.3 RXi Pharmaceuticals Corp Business Operation Conditions
Table Business Operation of RXi Pharmaceuticals Corp (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Proliferative Vitreoretinopathy (PVR) Therapeutics Sales Revenue 2016-2020, by Company, in USD Million
Table Global Proliferative Vitreoretinopathy (PVR) Therapeutics Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global Proliferative Vitreoretinopathy (PVR) Therapeutics Sales Revenue Share in 2020, by Company, in USD Million
Table Global Proliferative Vitreoretinopathy (PVR) Therapeutics Sales Volume 2016-2020, by Company, in Volume
Table Global Proliferative Vitreoretinopathy (PVR) Therapeutics Sales Volume Share 2016-2020, by Company, in Volume
Figure Global Proliferative Vitreoretinopathy (PVR) Therapeutics Sales Volume Share in 2020, by Company, in Volume
5.2 Regional Market by Company
Figure North America Proliferative Vitreoretinopathy (PVR) Therapeutics Market Concentration, in 2020
Figure Europe Proliferative Vitreoretinopathy (PVR) Therapeutics Market Market Concentration, in 2020
Figure Asia-Pacific Proliferative Vitreoretinopathy (PVR) Therapeutics MMarket Concentration, in 2020
Figure South America Proliferative Vitreoretinopathy (PVR) Therapeutics Market Concentration, in 2020
Figure Middle East & Africa Proliferative Vitreoretinopathy (PVR) Therapeutics Market Concentration, in 2020
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Hospital
Figure Proliferative Vitreoretinopathy (PVR) Therapeutics Demand in Hospital, 2016-2020, in USD Million
Figure Proliferative Vitreoretinopathy (PVR) Therapeutics Demand in Hospital, 2016-2020, in Volume
6.1.2 Demand in Clinic
Figure Proliferative Vitreoretinopathy (PVR) Therapeutics Demand in Clinic, 2016-2020, in USD Million
Figure Proliferative Vitreoretinopathy (PVR) Therapeutics Demand in Clinic, 2016-2020, in Volume
6.1.3 Demand in ASCs
Figure Proliferative Vitreoretinopathy (PVR) Therapeutics Demand in ASCs, 2016-2020, in USD Million
Figure Proliferative Vitreoretinopathy (PVR) Therapeutics Demand in ASCs, 2016-2020, in Volume
6.1.4 Demand in Others
Figure Proliferative Vitreoretinopathy (PVR) Therapeutics Demand in Others, 2016-2020, in USD Million
Figure Proliferative Vitreoretinopathy (PVR) Therapeutics Demand in Others, 2016-2020, in Volume
6.1.21 Demand in ·
Table Proliferative Vitreoretinopathy (PVR) Therapeutics Demand in ·, 2016-2020, in USD Million
Table Proliferative Vitreoretinopathy (PVR) Therapeutics Demand in ·, 2016-2020, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Proliferative Vitreoretinopathy (PVR) Therapeutics Demand Forecast 2021-2026, by Application, in USD Million
Figure Proliferative Vitreoretinopathy (PVR) Therapeutics Market Growth 2021-2026, by Application, in USD Million
Figure Proliferative Vitreoretinopathy (PVR) Therapeutics Market Share in 2026, by Application, in USD Million
Table Proliferative Vitreoretinopathy (PVR) Therapeutics Demand Forecast 2021-2026, by Application, in Volume
Table Proliferative Vitreoretinopathy (PVR) Therapeutics Market Growth 2021-2026, by Application, in Volume
Table Proliferative Vitreoretinopathy (PVR) Therapeutics Market Share in 2026, by Application, in Volume
6.4 Impact of the COVID-19 on the Demand
7 Region Operation
7.1 Regional Production
Table Proliferative Vitreoretinopathy (PVR) Therapeutics Production 2016-2020, by Region, in USD Million
Table Proliferative Vitreoretinopathy (PVR) Therapeutics Production 2016-2020, by Region, in Volume
7.2 Regional Market
Table Global Proliferative Vitreoretinopathy (PVR) Therapeutics Market 2016-2020, by Region, in USD Million
Table Global Proliferative Vitreoretinopathy (PVR) Therapeutics Market Share 2016-2020, by Region, in USD Million
Table Global Proliferative Vitreoretinopathy (PVR) Therapeutics Market 2016-2020, by Region, in Volume
Table Global Proliferative Vitreoretinopathy (PVR) Therapeutics Market Share 2016-2020, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Proliferative Vitreoretinopathy (PVR) Therapeutics Market Size and Growth 2016-2020, in USD Million
Figure North America Proliferative Vitreoretinopathy (PVR) Therapeutics Market Size and Growth 2016-2020, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Proliferative Vitreoretinopathy (PVR) Therapeutics Market Size 2016-2020, by Country, in USD Million
Table North America Proliferative Vitreoretinopathy (PVR) Therapeutics Market Size 2016-2020, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Proliferative Vitreoretinopathy (PVR) Therapeutics Market Size and Growth 2016-2020, in USD Million
Figure Europe Proliferative Vitreoretinopathy (PVR) Therapeutics Market Size and Growth 2016-2020, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Proliferative Vitreoretinopathy (PVR) Therapeutics Market Size 2016-2020, by Country, in USD Million
Table Europe Proliferative Vitreoretinopathy (PVR) Therapeutics Market Size 2016-2020, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Proliferative Vitreoretinopathy (PVR) Therapeutics Market Size and Growth 2016-2020, in USD Million
Figure Asia-Pacific Proliferative Vitreoretinopathy (PVR) Therapeutics Market Size and Growth 2016-2020, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Proliferative Vitreoretinopathy (PVR) Therapeutics Market Size 2016-2020, by Country, in USD Million
Table Asia-Pacific Proliferative Vitreoretinopathy (PVR) Therapeutics Market Size 2016-2020, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Proliferative Vitreoretinopathy (PVR) Therapeutics Market Size and Growth 2016-2020, in USD Million
Figure South America Proliferative Vitreoretinopathy (PVR) Therapeutics Market Size and Growth 2016-2020, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Proliferative Vitreoretinopathy (PVR) Therapeutics Market Size 2016-2020, by Country, in USD Million
Table South America Proliferative Vitreoretinopathy (PVR) Therapeutics Market Size 2016-2020, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Proliferative Vitreoretinopathy (PVR) Therapeutics Market Size and Growth 2016-2020, in USD Million
Figure Middle East & Africa Proliferative Vitreoretinopathy (PVR) Therapeutics Market Size and Growth 2016-2020, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Proliferative Vitreoretinopathy (PVR) Therapeutics Market Size 2016-2020, by Country, in USD Million
Table Middle East & Africa Proliferative Vitreoretinopathy (PVR) Therapeutics Market Size 2016-2020, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Proliferative Vitreoretinopathy (PVR) Therapeutics Market Forecast 2021-2026, by Region, in USD Million
Table Proliferative Vitreoretinopathy (PVR) Therapeutics Market Forecast 2021-2026, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion

List of Figure

List of Table
List of Table
1. Table Upstream Segment of Proliferative Vitreoretinopathy (PVR) Therapeutics
2. Table Application Segment of Proliferative Vitreoretinopathy (PVR) Therapeutics
3. Table Global Proliferative Vitreoretinopathy (PVR) Therapeutics Market 2016-2026, by Application, in USD Million
4. Table Major Company List of XOMA-089
5. Table Major Company List of Others
6. Table Global Proliferative Vitreoretinopathy (PVR) Therapeutics Market 2016-2020, by Type, in USD Million
7. Table Global Proliferative Vitreoretinopathy (PVR) Therapeutics Market 2016-2020, by Type, in Volume
8. Table Global Proliferative Vitreoretinopathy (PVR) Therapeutics Market Forecast 2021-2026, by Type, in USD Million
9. Table Global Proliferative Vitreoretinopathy (PVR) Therapeutics Market Forecast 2021-2026, by Type, in Volume
10. Table Novartis AG Overview List
11. Table Business Operation of Novartis AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
12. Table Promedior Inc Overview List
13. Table Business Operation of Promedior Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
14. Table RXi Pharmaceuticals Corp Overview List
15. Table Business Operation of RXi Pharmaceuticals Corp (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
16. Table Global Proliferative Vitreoretinopathy (PVR) Therapeutics Sales Revenue 2016-2020, by Company, in USD Million
17. Table Global Proliferative Vitreoretinopathy (PVR) Therapeutics Sales Revenue Share 2016-2020, by Company, in USD Million
18. Table Global Proliferative Vitreoretinopathy (PVR) Therapeutics Sales Volume 2016-2020, by Company, in Volume
19. Table Global Proliferative Vitreoretinopathy (PVR) Therapeutics Sales Volume Share 2016-2020, by Company, in Volume
20. Table Proliferative Vitreoretinopathy (PVR) Therapeutics Demand in ·, 2016-2020, in USD Million
21. Table Proliferative Vitreoretinopathy (PVR) Therapeutics Demand in ·, 2016-2020, in Volume
22. Table Regional Demand Comparison List
23. Table Major Application in Different Regions
24. Table Proliferative Vitreoretinopathy (PVR) Therapeutics Demand Forecast 2021-2026, by Application, in USD Million
25. Table Proliferative Vitreoretinopathy (PVR) Therapeutics Demand Forecast 2021-2026, by Application, in Volume
26. Table Proliferative Vitreoretinopathy (PVR) Therapeutics Market Growth 2021-2026, by Application, in Volume
27. Table Proliferative Vitreoretinopathy (PVR) Therapeutics Market Share in 2026, by Application, in Volume
28. Table Proliferative Vitreoretinopathy (PVR) Therapeutics Production 2016-2020, by Region, in USD Million
29. Table Proliferative Vitreoretinopathy (PVR) Therapeutics Production 2016-2020, by Region, in Volume
30. Table Global Proliferative Vitreoretinopathy (PVR) Therapeutics Market 2016-2020, by Region, in USD Million
31. Table Global Proliferative Vitreoretinopathy (PVR) Therapeutics Market Share 2016-2020, by Region, in USD Million
32. Table Global Proliferative Vitreoretinopathy (PVR) Therapeutics Market 2016-2020, by Region, in Volume
33. Table Global Proliferative Vitreoretinopathy (PVR) Therapeutics Market Share 2016-2020, by Region, in Volume
34. Table North America Proliferative Vitreoretinopathy (PVR) Therapeutics Market Size 2016-2020, by Country, in USD Million
35. Table North America Proliferative Vitreoretinopathy (PVR) Therapeutics Market Size 2016-2020, by Country, in Volume
36. Table Europe Proliferative Vitreoretinopathy (PVR) Therapeutics Market Size 2016-2020, by Country, in USD Million
37. Table Europe Proliferative Vitreoretinopathy (PVR) Therapeutics Market Size 2016-2020, by Country, in Volume
38. Table Asia-Pacific Proliferative Vitreoretinopathy (PVR) Therapeutics Market Size 2016-2020, by Country, in USD Million
39. Table Asia-Pacific Proliferative Vitreoretinopathy (PVR) Therapeutics Market Size 2016-2020, by Country, in Volume
40. Table South America Proliferative Vitreoretinopathy (PVR) Therapeutics Market Size 2016-2020, by Country, in USD Million
41. Table South America Proliferative Vitreoretinopathy (PVR) Therapeutics Market Size 2016-2020, by Country, in Volume
42. Table Middle East & Africa Proliferative Vitreoretinopathy (PVR) Therapeutics Market Size 2016-2020, by Country, in USD Million
43. Table Middle East & Africa Proliferative Vitreoretinopathy (PVR) Therapeutics Market Size 2016-2020, by Country, in Volume
44. Table Proliferative Vitreoretinopathy (PVR) Therapeutics Market Forecast 2021-2026, by Region, in USD Million
45. Table Proliferative Vitreoretinopathy (PVR) Therapeutics Market Forecast 2021-2026, by Region, in Volume
46. Table Price Factors List